China NMPA Product Recall - Flo-Thru Intraluminal Shunt

On July 18, 2022, the National Medical Products Administration (NMPA) of China published information regarding a voluntary product recall initiated by Synovis Life Technologies, Inc., a subsidiary of Baxter International Inc. This recall was reported by Baxter Medical Products Trading (Shanghai) Co., Ltd. The main issue identified pertains to a specific model and batch of the company's Flo-Thru Intraluminal Shunt coronary shunts, which were found to potentially contain "foreign matter." This discovery led to a Level 1 classification for the recall, indicating the highest risk category where use of the product could lead to serious adverse health consequences or death. The regulatory framework under the NMPA mandates such actions to safeguard public health and ensure medical device safety. As a result, Synovis Life Technologies, Inc. is required to remove these affected medical devices from the market. Detailed information concerning the specific product models, specifications, and batch numbers is provided in the official "Medical Device Recall Event Report Form" attached to the NMPA notice. This proactive measure underscores both the manufacturer's accountability and the NMPA's stringent oversight in maintaining product quality and patient safety within the medical device sector.